People

The integration of artificial intelligence into the workplace has sparked a flurry of legal and regulatory discussions in recent months.

Foley & Lardner LLP partner Nathaniel Lacktman, chair of firm’s national Telemedicine & Digital Health Industry Team and member of the American Telemedicine Association Board of Directors, offered insight on how providers might prepare if the U.S. Drug Enforcement Agency (DEA) issues regressive regulations on telemedicine prescribing in the Modern Healthcare article, “Specter of strict DEA prescribing rule rattles telehealth sector.”

Foley & Lardner LLP partner Louis Lehot offered insight on the biotech industry’s upcoming initial public offerings in the Bloomberg Law article, “Biotech IPO Hopefuls Ready Burst of Debuts After Rough Stretch.”